UNSPSC 51111770: Vinfosiltine

This classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula C51H72N5O10P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AW1UYE6Q9I, chemically known as vincaleukoblastine, o4-deacetyl-3-de(methoxycarbonyl)-3-((((1s)-1-(diethoxyphosphinyl)-2-methylpropyl)amino)carbonyl)- but generally known as vinfosiltine, which bears US NIH Compound Identifier 3086608.

UNSPSC 51111770 Vinfosiltine is a Commodity code under which state and local governments procure pharmaceutical products, medical supplies, and related health-system consumables, though recent solicitations show considerable variance in actual scope. The code encompasses naloxone and drug deactivation systems, generic pharmaceuticals and over-the-counter products sourced through wholesalers and direct-to-manufacturer channels, and emergency medical supplies including respiratory equipment, cardiac monitoring devices, and consumables for first-response operations. Issuing bodies include county health departments, state health and human services commissions, municipal fire departments, and regional cooperative purchasing alliances. Seminole County, Florida; the City of Tampa; the Texas Health and Human Services Commission; and the Minnesota Department of Administration represent recent buyers, with the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) serving as a multi-jurisdictional vehicle spanning state and local members across multiple states including Oregon.

Activity spans Florida, Texas, and Minnesota with multi-state reach through cooperative purchasing. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, response due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually; the City of Tampa's IFB 26P00145 (posted March 25, 2026, response due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, with an estimated contract value of $700,000 and a 5 percent bid discount for certified Small Local Business Enterprises; the Minnesota MMCAP RFP S1070000015802 (posted January 20, 2026, response due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and over-the-counter products distributed across state and local facilities; and the Texas Health and Human Services Commission RFI HHS0017013 (posted April 3, 2026, response due April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. The Tampa and Seminole County solicitations specify quarterly or rolling deliveries with express timelines, while the MMCAP procurement requires products available by May 15, 2026, with contracts effective July 1, 2026.